Athira Pharma Stock (NASDAQ:ATHA), Quotes and News Summary

Q: What sector and industry does Athira Pharma (ATHA) operate in?

Athira Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Athira Pharma Stock (NASDAQ: ATHA) stock price, news, charts, stock research, profile.

Open	$2.160
Close	$2.110
Volume / Avg.	111.525K / 372.351K
Day Range	2.110 - 2.260
52 Wk Range	1.330 - 4.298
Market Cap	$80.873M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	3.75%
Days to Cover	2.03

Recent News

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed lower by around 20 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Around $10M Bet On This Real Estate Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

FDA Rejects ImmunityBio's Bladder Cancer Therapy Filing

Shares of ImmunityBio (NASDAQ: IBRX) were down 55.1% on Thursday after management announced that FDA issued a complete response letter ("CRL") to its biologics license application ("BLA") seeking approval for the combination use of its lead pipeline candidate, Anktiva (N-803), in pa

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Athira Pharma Inc

Sector

Health Care

Industry

Pharmaceuticals

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small mol...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Athira Pharma (ATHA) stock?

You can purchase shares of Athira Pharma (NASDAQ: ATHA) through any online brokerage.

View our list of the best stock brokerages.

Who are Athira Pharma's (ATHA) competitors?

Other companies in Athira Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).

What is the target price for Athira Pharma (ATHA) stock?

The latest price target for Athira Pharma (NASDAQ: ATHA) was reported by JMP Securities on Friday, August 11, 2023. The analyst firm set a price target for 19.00 expecting ATHA to rise to within 12 months (a possible 800.43% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Athira Pharma (ATHA)?

The stock price for Athira Pharma (NASDAQ: ATHA) is $2.1101 last updated April 17, 2024 at 4:02 PM EDT.

Does Athira Pharma (ATHA) pay a dividend?

There are no upcoming dividends for Athira Pharma.

When is Athira Pharma (NASDAQ:ATHA) reporting earnings?

Athira Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Athira Pharma (ATHA) going to split?

There is no upcoming split for Athira Pharma.

What sector and industry does Athira Pharma (ATHA) operate in?

Athira Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-